Baltimore Mayor Brandon M. Scott has unveiled the terms of the settlement reached last month with Walgreens to resolve the city’s claims against the company for its role in fueling the opioid epidemic in Baltimore.
The city also said it has settled with manufacturer Johnson & Johnson, under terms to be announced at a later date.
Walgreens will pay $45 million by the end of this calendar year and the remainder by December 31, 2025. The city said it will use the entirety of the settlement for opioid remediation, with $2 million for the Maryland Peer Advisory Council, $1 million for We Our Us, $1 million for On Our Own of Maryland, $1 million for the Maryland Coalition of Families, $15 million for the city to establish comprehensive outreach services that operate 24/7, $5 million for 988 education and outreach, and $10 million for Baltimore Comprehensive Overdose Response to End the Epidemic (BCORE). The remainder of the money received by the City will be managed in accordance with Mayor Scott’s August 2024 executive order.
The city’s settlement with Walgreens is one of six that it has obtained stemming from its ongoing lawsuit against opioid distributors and manufacturers. It followed settlements with Allergan and CVS for $45 million each, Teva for $80 million, and Cardinal Health for $152.5 million, bringing the total of announced recoveries from opioid defendants to $402.5 million.
The trial against the remaining defendants—distributors McKesson and AmerisourceBergen—began last month and is ongoing in the Circuit Court for Baltimore City.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Florida Storm Surge Swamps Nuclear Plant, Pro Golfer’s Home, Many More 
Flooded Farms, Fouled Rivers, Dozens Dead: Helene’s Rising Toll 
Modeler KCC Puts Privately Insured Losses at $6.4B From Helene 
Tennessee Investigating Plastics Factory Where Helene Flooding Killed 11 Workers 
